Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Monistat line extensions

This article was originally published in The Tan Sheet

Executive Summary

J&J Personal Products expects Monistat 7 combination pack with pre-filled applicators for "less mess" to hit shelves in October. FDA approved supplemental NDA 17-450/S-052 on Aug. 7. J&J division also anticipates launching pre-filled version of Monistat 1 combo pack in November, although firm has not yet received FDA go-ahead. In separate letter for sNDA 20-827/S-006, agency approves increased font size for warning language on Monistat 3 cream...

You may also be interested in...



Monistat 1 extension

J&J Personal Products will launch Monistat 1 combination pack with pre-filled applicators in November, following FDA's Sept. 6 approval of supplemental NDA 21-308/S4. Monistat 7 pre-filled combo packs are expected to hit shelves in October (1"The Tan Sheet" Aug. 19, 2002, In Brief)...

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094417

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel